Skip navigation

DSpace JSPUI

DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

Learn More
DSpace logo
English
中文
  • Browse
    • Communities
      & Collections
    • Publication Year
    • Author
    • Title
    • Subject
  • Search TDR
  • Rights Q&A
    • My Page
    • Receive email
      updates
    • Edit Profile
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 醫學檢驗暨生物技術學系
Please use this identifier to cite or link to this item: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/77965
Title: 微核醣核酸-X在神經母細胞瘤中之抑癌角色
Tumor suppressive effects of a microRNA-X in human neuroblastoam
Authors: 李文博
Man-Pok Lei
Advisor: 胡忠怡
Keyword: 神經母細胞瘤,微核醣核酸,抑癌因子,PPARGC1B,
neuroblastoma,microRNA,tumor suppressor,PPARGC1B,
Publication Year : 2017
Degree: 碩士
Abstract: 神經母細胞瘤(Neuroblastoma, NB)為兒童癌症中最常見之顱外固態腫瘤,其佔兒童癌症死亡率約12%,而發生轉錄因子MYCN增幅的NB病人存活率較差。微核醣核酸(microRNA or miRNA)為一種非轉譯之小核醣核酸分子,透過轉錄後機制抑制標的基因的表現。過往miRNA研究中發現MYCN增幅的NB腫瘤與MYCN轉殖小鼠中皆有一群miRNA表現量顯著下降,包括miR-X。已知miR-X在非小細胞肺癌、腎臟惡性腫瘤與神經纖維肉瘤中表現量顯著減低,並具抑癌作用。初步分析腫瘤中miR-X表現量較高的NB病人,其存活率顯著較好。顯示miR-X在NB中可能有抑癌作用。然而其確實調控角色則尚不清楚。
分析台大兒童醫院40位NB病人於進行化療前收集的腫瘤檢體內miR-X表現量,發現臨床分期上風險較高的病人miR-X表現量顯著較低,而miR-X表現量高的病人的整體存活率與無事故存活率都較高。在六株人類NB細胞株中,有MYCN增幅的細胞株miR-X表現量有較低之趨勢。在有MYCN增幅的兩株NB細胞(SK-N-DZ,SK-N-BE)中以用慢病毒轉導使過度表現miR-X後細胞生長速度明顯減緩,分析細胞週期時發現有G0/G1停滯的現象;細胞非貼附生長能力、侵襲能力與遷移能力也顯著下降。顯示miR-X有抑制NB細胞腫瘤惡性程度的功能。分析過度表現miR-X後細胞的ATP產量與葡萄糖吸收量都有顯著上升,說明miR-X可調控細胞之糖類代謝。以微陣列(microarray)分析發現共151個基因在過表現miR-X後基因表現量顯著下降,其中15個基因為可能直接受miR-X調控表現之分子,我們鎖定在R2網路基因資料庫分析中顯示與NB臨床預後有關的PPARGC1B作後續研究。
PPARGC1B為一參與粒腺體新生(mitochondrial biogenesis)的基因,同時亦可調控細胞能量代謝。已知PPARGC1B在大腸癌及乳癌中扮演致癌角色,腫瘤細胞中PPARGC1B高表現已證實與增進癌細胞非貼附生長能力、降低細胞ATP產量生成相關。而進一步以RT-qPCR方法發現過度表現miR-X的兩NB細胞株,其PPARGC1B表現量確實下降,與微陣列分析結果符合。在人類NB細胞株中,具有MYCN增幅之SK-N-DZ與SK-N-BE細胞中PPARGC1B表現量較高,我們利用shRNA將SK-N-DZ細胞中PPARGC1B基因默化。而SK-N-DZ細胞在默化PPARGC1B後生長速度顯著下降,與過表現miR-X後的結果相符。
未來我們將通過reporter assay分析miR-X是否確實能直接調降PPARGC1B基因表現,同時探討PPARGC1B通過何種影響何種下游分子從而抑制NB細胞腫瘤惡性度;另外亦會建立miR-X剔除/默化的NB細胞株,從而確實其在NB中扮演抑癌角色的假設。
Neuroblastoma (NB) is an extracranial solid tumor with aggressive and metastatic features affecting young children. Patients with MYCN proto-oncogene amplification will have poor prognosis and survival. MicroRNA belongs to the short non-coding RNA family known to post-transcriptionally regulate the expression of their target genes, and play important roles in tumorigenesis. Recent miRNA profiling studies revealed a group of miRNAs were down-regulated in MYCN-amplified (MNA) NB, including miR-X, which was known as a tumor suppressor in non-small cell lung cancer and renal cell carcinoma. This suggests a tumor suppressor role of miR-X in NB.
Here we evaluated tumor miR-X expression in 40 primary NB tumors obtained from untreated patients, it was noted that patients with INSS low risk stages (stages 1, 2) or without MNA had a higher miR-X expression in the tumors. Patients with higher tumor miR-X expression had better survival. Human NB cell lines bearing MYCN amplification (SK-N-DZ and SK-N-BE) showed a relatively lower miR-X expression as compared to cells without MNA (SK-N-SH, SH-SY-5Y). Overexpression of miR-X in MNA-NB cells by lentiviral transduction downregulated cell proliferation, anchorage-independent colony formation, migration ability and matrigel invasiveness. Furthermore, overexpression of miR-X increased glucose uptake and ATP production in MNA NB cell lines, indicating its effect on regulating energy metabolism. Microarray analysis identified 151 genes were significantly downregulated in miR-X-overexpressed compared to the control SK-N-DZ cells. Of particular interest, PPARGC1B, which encodes PGC-1 that is involved in mitochondria biogenesis and regulating glucose metabolism, and has shown significant clinical impact in the public NB database R2, was found to be decreased in the miR-X-overexpressed cells. We then generated PPARGC1B knock down SK-N-DZ cell using shRNA. Knocking down PPARGC1B significantly inhibited SK-N-DZ cell growth and anchorage-independent clonogenic formation.
We will further investigate whether miR-X can inhibit PPARGC1B expression through direct targeting to its 3’-UTR using reporter assay. Secondary, the possible PPARGC1B down-stream targets will be analyzed using Western blot and RT-qPCR, to clarify the miR-X-PPARGC1B and its down-stream regulating pathway that is responsible to the phenotypic changes in the miR-X overexpressed NB cells. MiR-X knock out/down assay will be also necessary for validation of the tumor suppressive effects of miR-X in NB cell lines.
URI: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/77965
DOI: 10.6342/NTU201701838
Fulltext Rights: 未授權
Appears in Collections:醫學檢驗暨生物技術學系

Files in This Item:
File SizeFormat 
ntu-105-2.pdf
  Restricted Access
3.51 MBAdobe PDF
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved